Results reported here indicate that heteronemin induces antiproliferation in oral cancer cells by inhibiting activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and STAT3. The gene discussed is MAPK3; the disease is lip and oral cavity carcinoma.